Xermelo - Drug Details
๐Ÿ“Š Estimates Xermelo Dialyzability By Different_Modalities

Xermelo

Complete Drug Information

Drug Name
Xermelo
Trade Names
Xermelo
Pregnancy Category
AU: B3
Routes of Administration
Oral
Protein Binding
>99% (both telotristat ethyl and telotristat)%
Metabolism
Hydrolysis via carboxylesterases
Elimination
0.6 hours (telotristat ethyl), 5 hours (telotristat)
Excretion
Feces (92.8%), urine (less than 0.4%)
Formula
C27H26ClF3N6O3
Molar Mass
574.99
Volume of Distribution
C27H26ClF3N6O3

๐Ÿคฐ Pregnancy Category Information

Category: AU: B3

Drugs which have been taken by only a limited number of pregnant women and women of childbearing age, without an increase in the frequency of malformation or other direct or indirect harmful effects on the human fetus. Animal studies have shown evidence of an increased occurrence of fetal damage, the significance of which is considered uncertain in humans.